Cancer Synoptic Reporting Project Group

Space shortcuts

Page tree

You are viewing an old version of this page. View the current version.

Compare with Current View Page History

Version 1 Next »

Cancer Synoptic Reporting Project Group

07 February 2022 at 17:30 UTC

Attendees Scott Campbell Ian Green Paul Seegers Stefan Dubois Suzanne Santamaria Nicola Ingram Keng-Ling Wallin@laszlo Daniel Karlsson Thomas Ruediger. David Kwan Monica de Baca

Elaine Wooler Raj Dash Jim Case


Zoom - https://snomed.zoom.us/my/pathologycrg


Meeting Recording (GoogleDrive)

https://drive.google.com/file/d/1RGdxdmUBxUQVognh0EXwMximyTaBb40-/view?usp=sharing

Discussion items

ItemDescriptionOwnerNotesAction
1IHC

Scott Campbell

  1. Focus on synoptic reporting uses.
  2. Examples:
    1. Breast cancer her2 from breast tissue (typical scenario)
    2. breast cancer her2 from lymph node (metastatic scenario)

Note: This defers metastatic observable to the info model

a. her2 in breast tissue


b. her2 in breast cancer from lymph node


2Treatment effect

Scott Campbell

Continue discussion:

What are we measuring when assessing "treatment effect"?  

Is this a histologic change?  Viability of tumor cells?

  1. Primary site
  2. Lymph node


Note: SSA wonders about property in this model

  1. Primary site



  2. Lymph node

3Lymph nodes

Scott Campbell

Stefan Dubois

  1. Discuss approach to lymph node body structures and differences in naming/locations (example AJCC esophageal cancer vs. JES esophageal cancer)

2. Management of observables for lymph node involvement.  Example: 

Did not discuss
4AJCC update?

Jim Case

Any updates that can be shared?Jim Case meeting with AJCC on Wednesday 26-Jan to continue/finalize contract issues

Meeting Files

  File Modified
No files shared here yet.




Previous Meetings

TitleCreatorModified
No content found.

  • No labels